AI memory therapy is no longer a concept. It is here, clinically validated, and already helping dementia patients feel less lonely and more connected.
In this episode of Clinical Capital Conversations, Peter M. Kovacs speaks with Kompanion Care founder Peter Markus about Lilia, an AI-powered therapeutic platform that combines reminiscence therapy, family-generated memories, and digital biomarkers to deliver real clinical impact.
We explore:
If you want to understand where dementia care, digital therapeutics, and AI-driven monitoring are heading, this conversation is essential.
Timecode:
00:00 Introduction and Guest Introduction
00:23 Peter Markus's Background and Career Journey
01:26 The Birth of Kompanion Care
04:31 Innovative Technology Behind Lilia Platform
11:41 Challenges and Importance of Medical Software
15:23 Current Progress and Future Plans
22:17 Investment and Market Strategy
37:28 Conclusion and Final Thoughts
Subscribe to Clinical Capital Conversations for unfiltered discussions at the crossroads of science and capital. Investors, founders, and operators welcome.
Links:
Peter M. Kovacs LinkedIn: https://www.linkedin.com/in/petermkovacs/
Peter M. Kovacs Personal Website:https://www.petermkovacs.com/
PMK Group Website: https://www.pmk-group.com/
Guests:
Péter Márkus: https://www.linkedin.com/in/pmarkus/
Kompanion Care: https://www.kompanioncare.com/
